Metabolically Stable Chimeric Nucleic Acid Nanoprobe Artificial Biomarker for Cancer Urine Biopsy
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.5c02043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Gang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China. Hauptthemen laut MEDLINE: Peptide Nucleic Acids, Biomarkers, Tumor, Biosensing Techniques, DNA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China, State Key Laboratory of Natural and Biomimetic Drugs, Peking University.
Abstract (Originalsprache)
Urine biopsy based on in vitro probes has emerged as a promising method for disease diagnosis. Here, a nanoprobe (designated as GTP) was developed by functionalizing nanomaterials with a chimeric nucleic acid (comprising peptide nucleic acid (PNA) and DNA) and integrating it with an electrochemical biosensor for cancer diagnosis via urine biopsy. The GTP specifically responded to telomerase (TE) at tumor sites, releasing metabolically stable PNA reporters of GTP into the blood circulation. By further leveraging the high affinity of the PNA for hybridization, the PNA reporters in urine were sensitively quantified on an electrochemical surface, effectively translating in situ tumor marker information into detectable in vitro signals. Relying on the combination of GTPs and the electrochemical biosensor, triple-negative breast cancer in xenograft mice could be diagnosed as early as day 6 post-transplantation. The electrochemical urine biopsy demonstrated significant clinical potential for moving forward the diagnostic window and quantitatively monitoring cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China.
- Shandong Cancer Hospital and Institute, School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China.
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
ORCID-Profile: Yang Xiang, Jin Jiao
Förderung
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China
- State Key Laboratory of Natural and Biomimetic Drugs, Peking University
Zitieren
APA
Wang, G., Lu, P., Chen, M., Dong, Y., Jiao, J., Xiang, Y., & Jiao, J. (2025). Metabolically Stable Chimeric Nucleic Acid Nanoprobe Artificial Biomarker for Cancer Urine Biopsy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c02043
Vancouver
Wang G, Lu P, Chen M, Dong Y, Jiao J, Xiang Y, et al. Metabolically Stable Chimeric Nucleic Acid Nanoprobe Artificial Biomarker for Cancer Urine Biopsy. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c02043
BibTeX
@article{Wang2025,
author = {Wang, Gang and Lu, Peifen and Chen, Mingxuan and Dong, Yixi and Jiao, Jianwei and Xiang, Yang and Jiao, Jin},
title = {Metabolically Stable Chimeric Nucleic Acid Nanoprobe Artificial Biomarker for Cancer Urine Biopsy},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.5c02043}
}
EUVIMED